Mochida to Quit Filgrastim Biosimilar as Repeated Price Cuts Made It Unprofitable

July 28, 2022
Earlier this month, Mochida Pharmaceutical revealed that it is pulling the plug on its filgrastim biosimilar business, without disclosing a clear reason. Now, several people on the healthcare side tell Jiho they were told by drug reps that repeated price...read more